: iStockAnalyst.com Symbols Feed

Earnings Preview for Feb 9-13 - Earnings Preview

Fri, 06 Feb 2009 18:52:00 GMT

Activision Blizzard Inc. (ATVI) could top expectations. IntercontinentalExchange, Inc. (ICE) and Terex Corporation (TEX) could miss. Though nearly 400 companies are scheduled to report, traders are going to keep a close eye on Washington. Treasury Secretary Timothy Geithner will announce a revised bank bailout plan on Monday. This plan could include the creation of a bad bank to absorb distressed debts (what TARP was[More...]

Stem Cell & Regenerative Medicine Stocks Surge in Past Month

Sat, 20 Dec 2008 00:03:00 GMT

The accompanying table (click to enlarge) includes the Top 10 Rated companies among a total of 64 and statistics for the ETF Innovators (ETFI) Cosmetic and Reconstructive Medicine (CRM) Index, which includes companies with market caps over $100M engaged in cosmetic medicine products, regenerative medicine + stem cells, orthopedic repair, joint replacements, and cardiovascular (heart + blood vessels) treatments. The Top 10 Rated companies are dominated by those focusing on cardiovascular[More...]

Indices Break Down from Consolidation Patterns in Late Afternoon Sell-Off

Wed, 13 Aug 2008 01:43:00 GMT

Wall Street had an afternoon sell-off that broke the mid day consolidation patterns and took the blue chip indices to pretty sharp losses, particularly on the Dow and S&P 500.[More...]

Analyst Comments: Dean Foods, AngioDynamics, Siliconware, Akamai

Fri, 04 Jul 2008 17:34:00 GMT

Dean Foods Company (DF) faced a challenging 2007 due to increased dairy costs. Though costs are expected to be volatile in 2008, the decline in the stock price has provided a buying opportunity, since any relief from high dairy costs will dramatically acc[More...]

Trading Ideas: Waxing Positive

Tue, 01 Jul 2008 13:47:51 GMT

We have been downbeat and sticking to the short side for many of our recent recommendations...[More...]

Analyst Comments: Select Comfort, Puget Energy, VNUS Medical, Vital Signs, Virgin Media, UST Inc, Valspar

Tue, 12 Feb 2008 16:40:52 GMT

Select Comfort Corporation's (SCSS) fourth quarter results came in below the company's bearish mid-quarter guidance. The company's sales trends continue to deteriorate and its profit margins are contracting. In addition, Select Comfort did not provide specific sales and earnings guidance, as it did in previous...[More...]

Friday Pre-Market

Fri, 08 Feb 2008 13:53:22 GMT

Good morning. It's Friday and there's not much market-moving news to discuss as earnings season starts to wind down and there's no significant economic data to report. Many traders are feeling tired and more the ready for the weekend to begin after the la[More...]

Analyst Comments: Infosys, Critical Therapeutics, Starwood Hotels & Resorts, Forest Laboratories, VNUS Medical Technologies

Wed, 16 Jan 2008 17:50:54 GMT

Zacks information technology analyst Abdul Saleh rates a Hold to software solutions firm Infosys Technologies Ltd. INFY) in his latest report. Here we find out why:'INFY reported stronger-than-expected revenues and earnings for 3Q08. It continues to strengthen strategic alliances and reorganize businesses in order to counter the effects of a strong rupee. The company was able to improve operating margins in the third quarter despite a higher...[More...]

NASDAQ Technical Picture - Profit Taking on Higher Volume

Thu, 04 Oct 2007 11:03:42 GMT

The Nasdaq was down 0.64% to close at 2729 on sligh[More...]

NASDAQ Technical Picture - Bulls Regain Momentum

Thu, 09 Aug 2007 06:10:05 GMT

Early strength was triggered by solid earnings in a few names including CSCO, which helped the NAZ outperform. Also some[More...]

Citigroup, Dow Chemical, Fannie Mae big movers

Fri, 08 May 2009 22:20:00 GMT

NEW YORK - Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market:
The bank said it planned to convert $33 billion of preferred shares into common stock to meet requirements of regulators' "stress test."
The government's "stress test" results showed the regional bank needed to raise $1.1 billion, which an analyst had said it could do.

[More...]

Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment

Wed, 10 Jun 2009 09:56:00 GMT

Journal of Vascular & Interventional Radiology Cites Improved Recovery and Quality-of-Life with VNUS Technology[More...]

Small Cap Sentinel: A Growing Body of Evidence

Mon, 08 Jun 2009 10:26:00 GMT

SenoRx, Inc. believes that a breast cancer patient treated with its Contura Multi-Lumen Balloon receives a more targeted dose of radiation while minimizing radiation to healthy surrounding tissue such as the skin and ribs than those treated with whole breast irradiation or with a single-lumen balloon. A growing and compelling body of scientific data suggests SenoRx is right.[More...]

A Milestone of Opportunity for VNUS Medical Technologies

Mon, 08 Jun 2009 09:57:00 GMT

Over Half a Million Varicose Vein Patients Treated with VNUS Closure Procedure Worldwide[More...]

Covidien Announces Definitive Agreement to Acquire VNUS Medical Technologies, Inc.

Fri, 08 May 2009 11:50:00 GMT

Covidien (NYSE: COV) and VNUS Medical Technologies, Inc. (NASDAQ: VNUS) today announced that Covidien has reached a definitive agreement to acquire VNUS, a developer of medical devices for minimally invasive treatment of venous reflux disease.
"The acquisition of VNUS will allow Covidien to expand its presence in the vascular market and is in line with our strategy of becoming a leading partner with vascular surgeons and interventional radiologists," said Joe Almeida, President, Medical Devices, Covidien.
"By joining Covidien, VNUS gains access to extended global resources to further drive the growth of VNUS products around the world," said Brian Farley, President and Chief Executive Officer, VNUS.

[More...]

VNUS Medical Technologies Record First-Quarter 2009 Results: 31% Revenue Growth and Record First Quarter Profitability

Fri, 08 May 2009 11:49:00 GMT

Medical Technologies, Inc. (Nasdaq:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous disease, today announced its financial results for the first quarter ended March 31, 2009.
Net revenues for the first quarter of 2009 included net product revenues and royalty revenues.
Disposable catheters and device unit sales increased in the first quarter of 2009 by 33% compared to the first quarter of 2008 and decreased 7% sequentially.

[More...]

Small Cap Sentinel: Innovation and Speed to Market

Thu, 30 Apr 2009 10:26:00 GMT

In the small cap world, innovation and speed to market can be the difference between achieving revenue and a good idea that dies on the proverbial vine. For investors, the ability to identify a company exemplifying these attributes can be paramount.[More...]

VNUS Medical Technologies to Report First-Quarter 2009 Results and Webcast Teleconference on May 8

Tue, 28 Apr 2009 15:58:00 GMT

VNUS® Medical Technologies, Inc. (Nasdaq:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it plans to report its financial results for the first quarter ended March 31, 2009, before market on May 8.[More...]

NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology

Fri, 03 Apr 2009 06:55:00 GMT

Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO[More...]

VNUS Medical Technologies to Present at the Sidoti & Company 13th Annual New York Emerging Growth Institutional Investor Forum

Thu, 19 Mar 2009 16:35:00 GMT

VNUS Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Sidoti & Company 13th Annual Emerging Growth Institutional Investor Forum, to be held March 24 - 25, 2009, at The Grand Hyatt Hotel in New York City. The management speaker will be Peter Osborne, Chief Financial Officer and Vice President of Finance and Administration.[More...]